ID25639A - ALKIL, ARYL OR HETEROARILAMIDE SUBSTITUTED N-HYDROXY-2- (ALKIL, ARYL, OR SULFANIL HETEROARIL, SULFINIL OR SULFONIL) -3 AS MATHOPHYRIC MATRIX INHIBITOR - Google Patents
ALKIL, ARYL OR HETEROARILAMIDE SUBSTITUTED N-HYDROXY-2- (ALKIL, ARYL, OR SULFANIL HETEROARIL, SULFINIL OR SULFONIL) -3 AS MATHOPHYRIC MATRIX INHIBITORInfo
- Publication number
- ID25639A ID25639A IDW20001549A ID20001549A ID25639A ID 25639 A ID25639 A ID 25639A ID W20001549 A IDW20001549 A ID W20001549A ID 20001549 A ID20001549 A ID 20001549A ID 25639 A ID25639 A ID 25639A
- Authority
- ID
- Indonesia
- Prior art keywords
- alkil
- aryl
- mathophyric
- heteroarilamide
- sulfinil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2637298A | 1998-02-19 | 1998-02-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID25639A true ID25639A (en) | 2000-10-19 |
Family
ID=21831431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20001549A ID25639A (en) | 1998-02-19 | 1998-08-26 | ALKIL, ARYL OR HETEROARILAMIDE SUBSTITUTED N-HYDROXY-2- (ALKIL, ARYL, OR SULFANIL HETEROARIL, SULFINIL OR SULFONIL) -3 AS MATHOPHYRIC MATRIX INHIBITOR |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1054858A1 (en) |
JP (1) | JP2002503717A (en) |
KR (1) | KR20010041089A (en) |
CN (1) | CN1213021C (en) |
AU (1) | AU757719B2 (en) |
BG (1) | BG104782A (en) |
BR (1) | BR9815781A (en) |
CA (1) | CA2320469A1 (en) |
EA (1) | EA003283B1 (en) |
EE (1) | EE200000471A (en) |
GE (1) | GEP20022797B (en) |
HR (1) | HRP20000543A2 (en) |
HU (1) | HUP0101837A3 (en) |
ID (1) | ID25639A (en) |
IL (1) | IL137566A0 (en) |
NO (1) | NO20004093L (en) |
NZ (1) | NZ506184A (en) |
PL (1) | PL342548A1 (en) |
SK (1) | SK12332000A3 (en) |
TR (1) | TR200002423T2 (en) |
WO (1) | WO1999042436A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9814643A (en) | 1997-11-14 | 2000-10-03 | Searle & Co | Aromatic hydroxamic acid sulfone metalloprotease inhibitor |
US20010039287A1 (en) | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
AR035312A1 (en) * | 1999-01-27 | 2004-05-12 | Wyeth Corp | HYDROXAMIC ACID COMPOUNDS CONTAINING ALQUINYL AS MATRIX / TACE METALOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITION THAT INCLUDE THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
US6358980B1 (en) * | 1999-01-27 | 2002-03-19 | American Cyanamid Company | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors |
US6800646B1 (en) | 1999-02-08 | 2004-10-05 | Pharmacia Corporation | Sulfamato hydroxamic acid metalloprotease inhibitor |
IL144783A0 (en) | 1999-02-08 | 2002-06-30 | Searle & Co | Sulfamato hydroxamic acid metalloprotease inhibitor |
CA2398561A1 (en) * | 2000-01-27 | 2001-08-02 | American Cyanamid Company | Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
US20020002152A1 (en) | 2000-04-14 | 2002-01-03 | Craig Richard A. | Hydrazide and alkoxyamide angiogenesis inhibitors |
AR028537A1 (en) * | 2000-04-14 | 2003-05-14 | Abbott Lab | HYDRAZIDS AND INHIBITING ALCOXIAMIDS OF ANGIOGENESIS |
US6683093B2 (en) | 2000-05-12 | 2004-01-27 | Pharmacia Corporation | Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
BR0209525A (en) | 2001-05-11 | 2004-03-09 | Pharmacia Corp | Aromatic sulfone hydroxamates and their use as protease inhibitors |
AU2003221786A1 (en) | 2002-04-25 | 2003-11-10 | Pharmacia Corporation | Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
US20040167182A1 (en) * | 2002-06-25 | 2004-08-26 | Becker Daniel P. | Hydroxamic acid and amide compounds and their use as protease inhibitors |
US7098241B2 (en) | 2002-12-16 | 2006-08-29 | Hoffmann-La Roche Inc. | Thiophene hydroxamic acid derivatives |
JP2008518923A (en) * | 2004-11-01 | 2008-06-05 | ヌアダ,リミテッド・ライアビリティ・カンパニー | Compounds and methods of use thereof |
FR2917427B1 (en) * | 2007-06-18 | 2009-08-21 | Galderma Res & Dev | TACE INHIBITORS IN ACNE TREATMENT |
FR2947268B1 (en) * | 2009-06-30 | 2011-08-26 | Galderma Res & Dev | NOVEL BENZENE-SULFONAMIDE COMPOUNDS, PROCESS FOR THE SYNTHESIS AND THEIR USE IN MEDICINE AND COSMETICS |
AU2013292076B2 (en) * | 2012-07-18 | 2017-02-23 | Proyecto De Biomedicina Cima, S.L. | New antifibrinolytic compounds |
WO2016032120A1 (en) * | 2014-08-27 | 2016-03-03 | 씨제이헬스케어 주식회사 | Novel amino-phenyl-sulfonyl-acetate derivative and use thereof |
KR101641023B1 (en) * | 2014-08-27 | 2016-07-20 | 씨제이헬스케어 주식회사 | Novel amino-phenyl-sulfonyl-acetate derivatives and use thereof |
CN107188837B (en) * | 2017-06-06 | 2019-05-28 | 温州大学 | A kind of synthetic method of α-acyl group high allyl thio-ether type compounds |
CA3115038A1 (en) | 2018-10-04 | 2020-04-09 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Egfr inhibitors for treating keratodermas |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827305D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5902791A (en) * | 1994-01-22 | 1999-05-11 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
JPH10501806A (en) * | 1994-06-22 | 1998-02-17 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | Metalloproteinase inhibitors |
TR199902095T2 (en) * | 1997-02-27 | 1999-12-21 | American Cyanamid Company | Amides as matrix metalloproteinase inhibitors |
JPH11199512A (en) * | 1997-10-24 | 1999-07-27 | Pfizer Prod Inc | Use of mmp-13 selective inhibitor for the treatment of arthrosis deformans and other mmp-mediated disease |
BR9814643A (en) * | 1997-11-14 | 2000-10-03 | Searle & Co | Aromatic hydroxamic acid sulfone metalloprotease inhibitor |
-
1998
- 1998-08-26 HU HU0101837A patent/HUP0101837A3/en unknown
- 1998-08-26 EP EP98943392A patent/EP1054858A1/en not_active Withdrawn
- 1998-08-26 AU AU91201/98A patent/AU757719B2/en not_active Ceased
- 1998-08-26 ID IDW20001549A patent/ID25639A/en unknown
- 1998-08-26 WO PCT/US1998/017633 patent/WO1999042436A1/en not_active Application Discontinuation
- 1998-08-26 CN CNB988139669A patent/CN1213021C/en not_active Expired - Fee Related
- 1998-08-26 SK SK1233-2000A patent/SK12332000A3/en unknown
- 1998-08-26 EE EEP200000471A patent/EE200000471A/en unknown
- 1998-08-26 JP JP2000532389A patent/JP2002503717A/en active Pending
- 1998-08-26 PL PL98342548A patent/PL342548A1/en unknown
- 1998-08-26 EA EA200000849A patent/EA003283B1/en not_active IP Right Cessation
- 1998-08-26 GE GEAP19985554A patent/GEP20022797B/en unknown
- 1998-08-26 NZ NZ506184A patent/NZ506184A/en unknown
- 1998-08-26 TR TR2000/02423T patent/TR200002423T2/en unknown
- 1998-08-26 BR BR9815781-7A patent/BR9815781A/en not_active Application Discontinuation
- 1998-08-26 CA CA002320469A patent/CA2320469A1/en not_active Abandoned
- 1998-08-26 KR KR1020007009128A patent/KR20010041089A/en not_active Application Discontinuation
- 1998-08-26 IL IL13756698A patent/IL137566A0/en unknown
-
2000
- 2000-08-16 NO NO20004093A patent/NO20004093L/en unknown
- 2000-08-18 HR HR20000543A patent/HRP20000543A2/en not_active Application Discontinuation
- 2000-09-19 BG BG104782A patent/BG104782A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1054858A1 (en) | 2000-11-29 |
NO20004093L (en) | 2000-10-03 |
CN1213021C (en) | 2005-08-03 |
EE200000471A (en) | 2002-02-15 |
GEP20022797B (en) | 2002-09-25 |
SK12332000A3 (en) | 2001-02-12 |
HUP0101837A3 (en) | 2001-11-28 |
PL342548A1 (en) | 2001-06-18 |
TR200002423T2 (en) | 2001-01-22 |
WO1999042436A1 (en) | 1999-08-26 |
CA2320469A1 (en) | 1999-08-26 |
AU9120198A (en) | 1999-09-06 |
EA200000849A1 (en) | 2001-04-23 |
AU757719B2 (en) | 2003-03-06 |
BG104782A (en) | 2001-08-31 |
BR9815781A (en) | 2000-11-07 |
CN1291183A (en) | 2001-04-11 |
KR20010041089A (en) | 2001-05-15 |
NO20004093D0 (en) | 2000-08-16 |
JP2002503717A (en) | 2002-02-05 |
EA003283B1 (en) | 2003-04-24 |
IL137566A0 (en) | 2001-07-24 |
NZ506184A (en) | 2003-05-30 |
HUP0101837A2 (en) | 2001-10-28 |
HRP20000543A2 (en) | 2001-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID25639A (en) | ALKIL, ARYL OR HETEROARILAMIDE SUBSTITUTED N-HYDROXY-2- (ALKIL, ARYL, OR SULFANIL HETEROARIL, SULFINIL OR SULFONIL) -3 AS MATHOPHYRIC MATRIX INHIBITOR | |
DK2253620T3 (en) | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN-TYROSINKINASE INHIBITORS | |
FI4209U1 (en) | New compounds | |
ID23287A (en) | SUBSTITUTED TRISICLIC | |
ATE293099T1 (en) | 2-(2-METHYLPHENYL)-3,4-DIHYDRO-2H-PYRROLE DERIVA E | |
ID28874A (en) | INHIBITOR PHOSPHODIESTERAGE 4, FTALAZINA DOWN. | |
ATE272622T1 (en) | 2-(2-CHLORPHENYL)-3,4-DIHYDRO-2H-PYRROLE DERIVATIVE | |
FR2777750B1 (en) | SEASONING | |
DE59800203D1 (en) | Drill, screwdriver or impact drill | |
DE59912532D1 (en) | SUBSTITUTED ACYLAMINOPHENYL-URACILE | |
DE59912188D1 (en) | SUBSTITUTED PHENYLURACILE | |
DE59911610D1 (en) | SUBSTITUTED BENZOYLCYCLOHEXANDIONE | |
DE29800419U1 (en) | Hole surround | |
DE69932256D1 (en) | ELECTROLUMINIZING, ORGANIC ELEMENT | |
DE29810876U1 (en) | screwdriver | |
ES1043277Y (en) | DRAWER. | |
ES1039413Y (en) | NEW CARD-SPORTSMAN. | |
IDP000021799A (en) | SUBSTITUTED PIROLUM COMPOUNDS | |
IDP000021790A (en) | SUBSTITUTED PIROLUM COMPOUNDS | |
SE9803669D0 (en) | Novel compounds | |
SE9804494D0 (en) | Novel compounds | |
SE9800458D0 (en) | Novel compounds | |
SE9801397D0 (en) | Novel compounds | |
SE9801989D0 (en) | Novel compounds | |
SE9804211D0 (en) | Novel compounds |